Who
Amy B. Wechsler
Director
Company insider
Files Form 4 as: Director, Bausch Health Companies; Director, Damora Therapeutics.
In numbers
- Trades disclosed
- 62
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $351K
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 17 Jun 2016
- Last trade
- 30 Sep 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 2 Oct 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | $6,8741,179 at $5.83 | filing |
| 30 Jun 2026filed 2 Jul 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | $6,8721,394 at $4.93 | filing |
| 30 Jun 2026filed 2 Jul 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | $6,8721,394 at $4.93 | filing |
| 22 May 2026filed 26 May 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | —45,871 at $0.00 | filing |
| 22 May 2026filed 26 May 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | —45,871 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | $6,8741,273 at $5.40 | filing |
| 31 Mar 2026filed 2 Apr 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | $6,8741,273 at $5.40 | filing |
| 31 Dec 2025filed 2 Jan 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | —989 at $0.00 | filing |
| 31 Dec 2025filed 2 Jan 2026 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | —989 at $0.00 | filing |
| 30 Sep 2025filed 2 Oct 2025 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | —1,065 at $0.00 | filing |
| 30 Jun 2025filed 2 Jul 2025 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | —1,032 at $0.00 | filing |
| 18 Jun 2025filed 20 Jun 2025 | DMRA Damora Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —720 at $0.00 | filing |
| 16 May 2025filed 20 May 2025 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | —54,347 at $0.00 | filing |
| 31 Mar 2025filed 1 Apr 2025 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | $6,8711,062 at $6.47 | filing |
| 31 Dec 2024filed 2 Jan 2025 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | $6,867852 at $8.06 | filing |
| 11 Oct 2024filed 15 Oct 2024 | DMRA Damora Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —720 at $0.00 | filing |
| 11 Oct 2024filed 15 Oct 2024 | DMRA Damora Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —480 at $0.00 | filing |
| 30 Sep 2024filed 1 Oct 2024 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | $6,871842 at $8.16 | filing |
| 28 Jun 2024filed 1 Jul 2024 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | $6,872986 at $6.97 | filing |
| 17 May 2024filed 20 May 2024 | BHC Bausch Health CompaniesPharmaceuticals | SEC FORM 4 Code A | —35,360 at $0.00 | filing |
News
Contrasting Ocular Therapeutix (NASDAQ:OCUL) and Bausch Health Cos (NYSE:BHC)BHC · dailypolitical.com · 13 Oct 2026Contrasting Bausch Health Cos (NYSE:BHC) and Journey Medical (NASDAQ:DERM)BHC · themarketsdaily.com · 8 Oct 2026
0 headlines in the last 90 days name Amy B. Wechsler; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.